Omeros Stock Today
| OMER Stock | USD 3.21 0.13 3.89% |
Performance0 of 100
| Odds Of DistressOver 65
|
Omeros is selling at 3.21 as of the 18th of April 2024; that is -3.89 percent decrease since the beginning of the trading day. The stock's lowest day price was 3.2. Omeros has more than 65 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Omeros are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 21st of October 2023 and ending today, the 18th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 8th of October 2009 | Category Healthcare | Classification Health Care |
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company has 57.94 M outstanding shares of which 13.29 M shares are now shorted by private and institutional investors with about 32.44 trading days to cover. More on Omeros
Moving against Omeros Stock
| 0.61 | SABSW | SAB Biotherapeutics | PairCorr |
| 0.5 | VALN | Valneva SE ADR Financial Report 2nd of May 2024 | PairCorr |
| 0.47 | DOMH | Dominari Holdings | PairCorr |
| 0.41 | VBIV | VBI Vaccines Financial Report 20th of May 2024 | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 14th of May 2024
Omeros Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Omeros' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Omeros or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman | Gregory Demopulos | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Health Care, Pharmaceuticals, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Omeros report their recommendations after researching Omeros' financial statements, talking to executives and customers, or listening in on Omeros' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Omeros. The Omeros consensus assessment is calculated by taking the average forecast from all of the analysts covering Omeros. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators related to Omeros' liquidity, profitability, solvency, and operating efficiency, Omeros may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. Financial strength of Omeros is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Omeros' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Omeros' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. Omeros' bond ratings measure its overall creditworthiness, which in many ways corresponds to the cost of borrowing for an issuer. These ratings assign a letter grade to all of Omeros' outstanding corporate bonds that indicate their credit quality. We use reports published by private self-sufficient rating services such as Standard & Poor's or Fitch Ratings Inc. to evaluate a bond issuer's financial strength or its ability to pay a bond's principal and interest. Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Omeros' financial leverage. It provides some insight into what part of Omeros' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Omeros (OMER) is traded on NASDAQ Exchange in USA. It is located in The Omeros Building, Seattle, WA, United States, 98119 and employs 198 people. Omeros is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 198.74 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Omeros's market, we take the total number of its shares issued and multiply it by Omeros's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Omeros conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 57.94 M outstanding shares of which 13.29 M shares are now shorted by private and institutional investors with about 32.44 trading days to cover.
Omeros currently holds about 122.56 M in cash with 74.73 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.95.
Check Omeros Probability Of Bankruptcy
Ownership AllocationOmeros has a total of 57.94 Million outstanding shares. 30% of Omeros outstanding shares are owned by third-party entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Omeros Ownership Details
Omeros Stock Price Odds Analysis
In regard to a normal probability distribution, the odds of Omeros jumping above the current price in 90 days from now is about 86.86%. The Omeros probability density function shows the probability of Omeros stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 3.2373. This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Omeros will likely underperform. Additionally, omeros has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Omeros to move above the current price in 90 days from now is about 86.86 (This Omeros probability density function shows the probability of Omeros Stock to fall within a particular range of prices over 90 days) .
Omeros Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Omeros that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Omeros' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Omeros' value.| Instituion | Recorded On | Shares | |
| Royal Bank Of Canada | 2023-12-31 | 508.9 K | |
| Ubs Group Ag | 2023-12-31 | 494.5 K | |
| Charles Schwab Investment Management Inc | 2023-12-31 | 469.2 K | |
| Nomura Holdings Inc | 2023-12-31 | 383.1 K | |
| Morgan Stanley - Brokerage Accounts | 2023-12-31 | 282.4 K | |
| Group One Trading, Lp | 2023-12-31 | 230.9 K | |
| Bank Of New York Mellon Corp | 2023-12-31 | 202.3 K | |
| Bridgeway Capital Management, Llc | 2023-12-31 | 186.3 K | |
| First Trust Advisors L.p. | 2023-12-31 | 172.8 K | |
| Ingalls & Snyder Llc | 2023-12-31 | 4.5 M | |
| Blackrock Inc | 2023-12-31 | 4.3 M |
Omeros Historical Income Statement
Omeros Income Statement is one of the three primary financial statements used for reporting Omeros's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Omeros revenue and expense. Omeros Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Omeros' Non Operating Income Net Other is relatively stable compared to the past year. As of 04/18/2024, Net Income Applicable To Common Shares is likely to grow to about 57.3 M, though Interest Expense is likely to grow to (29.3 M). View More FundamentalsOmeros Stock Against Markets
Picking the right benchmark for Omeros stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Omeros stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Omeros is critical whether you are bullish or bearish towards Omeros at a given time. Please also check how Omeros' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Omeros without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Piotroski F Score Now
Piotroski F ScoreGet Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
| All Next | Launch Module |
Omeros Corporate Directors
Omeros corporate directors refer to members of an Omeros board of directors. The board of directors generally takes responsibility for the Omeros' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Omeros' board members must vote for the resolution. The Omeros board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Thomas Cable | Lead Independent Director | Profile | |
| Ray Aspiri | Independent Director | Profile | |
| Thomas Bumol | Independent Director | Profile | |
| Leroy Hood | Independent Director | Profile |
How to buy Omeros Stock?
Before investing in Omeros, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Omeros. To buy Omeros stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Omeros. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Omeros stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Omeros stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Omeros stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Omeros, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Omeros Stock please use our How to Invest in Omeros guide.
Already Invested in Omeros?
The danger of trading Omeros is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Omeros is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Omeros. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Omeros is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Omeros is a strong investment it is important to analyze Omeros' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Omeros' future performance. For an informed investment choice regarding Omeros Stock, refer to the following important reports: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omeros. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. To learn how to invest in Omeros Stock, please use our How to Invest in Omeros guide.Note that the Omeros information on this page should be used as a complementary analysis to other Omeros' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for Omeros Stock analysis
When running Omeros' price analysis, check to measure Omeros' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Omeros is operating at the current time. Most of Omeros' value examination focuses on studying past and present price action to predict the probability of Omeros' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Omeros' price. Additionally, you may evaluate how the addition of Omeros to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Stocks Directory Find actively traded stocks across global markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
Is Omeros' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omeros. If investors know Omeros will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omeros listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.84) | Revenue Per Share (0.48) | Quarterly Revenue Growth 0.149 | Return On Assets (0.21) | Return On Equity (5.76) |
The market value of Omeros is measured differently than its book value, which is the value of Omeros that is recorded on the company's balance sheet. Investors also form their own opinion of Omeros' value that differs from its market value or its book value, called intrinsic value, which is Omeros' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omeros' market value can be influenced by many factors that don't directly affect Omeros' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Omeros' value and its price as these two are different measures arrived at by different means. Investors typically determine if Omeros is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omeros' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.